Published in Lancet Neurol on March 01, 2009
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Early diffusion-weighted imaging and perfusion-weighted imaging lesion volumes forecast final infarct size in DEFUSE 2. Stroke (2013) 1.25
Imaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review. Expert Rev Cardiovasc Ther (2011) 1.14
Defining an Acidosis-Based Ischemic Penumbra from pH-Weighted MRI. Transl Stroke Res (2011) 1.11
Imaging of acute stroke. Nat Rev Neurol (2010) 1.09
Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE). Stroke (2009) 1.01
Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence. J Cereb Blood Flow Metab (2010) 1.01
Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. J Cereb Blood Flow Metab (2011) 0.99
Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp Neurol (2012) 0.96
Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res (2015) 0.96
MR imaging of oxygen extraction and neurovascular coupling. Stroke (2013) 0.95
Magnetic resonance imaging in acute ischemic stroke treatment. J Stroke (2014) 0.95
Prehospital stroke care: new prospects for treatment and clinical research. Neurology (2013) 0.92
Early identification of potentially salvageable tissue with MRI-based predictive algorithms after experimental ischemic stroke. J Cereb Blood Flow Metab (2013) 0.84
Safety and clinical outcome of thrombolysis in ischaemic stroke using a perfusion CT mismatch between 3 and 6 hours. PLoS One (2011) 0.83
Stroke-related translational research. Arch Neurol (2011) 0.83
Age and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic stroke. Yale J Biol Med (2012) 0.83
The vascular mean transit time: a surrogate for the penumbra flow threshold? J Cereb Blood Flow Metab (2010) 0.82
Spontaneous reperfusion after in situ thromboembolic stroke in mice. PLoS One (2012) 0.82
Magnetic resonance imaging to visualize stroke and characterize stroke recovery: a review. Front Neurol (2013) 0.81
Effect of extended CT perfusion acquisition time on ischemic core and penumbra volume estimation in patients with acute ischemic stroke due to a large vessel occlusion. PLoS One (2015) 0.81
Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue. Neurology (2015) 0.81
Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion therapy. Stroke (2013) 0.80
Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J Stroke Cerebrovasc Dis (2010) 0.80
Recovery Potential After Acute Stroke. Front Neurol (2015) 0.79
Is CT-Based Perfusion and Collateral Imaging Sensitive to Time Since Stroke Onset? Front Neurol (2015) 0.79
Reperfusion therapies for acute ischemic stroke: an update. Curr Cardiol Rev (2014) 0.79
Perfusion-diffusion Mismatch Predicts Early Neurological Deterioration in Anterior Circulation Infarction without Thrombolysis. Curr Neurovasc Res (2015) 0.75
Identification of imaging selection patterns in acute ischemic stroke patients and the influence on treatment and clinical trial enrollment decision making. Int J Stroke (2016) 0.75
CT-perfusion stroke imaging: a threshold free probabilistic approach to predict infarct volume compared to traditional ischemic thresholds. Sci Rep (2017) 0.75
Quantitative accuracy of computed tomography perfusion under low-dose conditions, measured using a hollow-fiber phantom. Jpn J Radiol (2017) 0.75
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10
Stroke. Lancet (2008) 9.51
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust (2003) 4.24
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport (2002) 3.31
Total synthesis of a functional designer eukaryotic chromosome. Science (2014) 3.31
Functional neuroimaging studies of motor recovery after stroke in adults: a review. Stroke (2003) 2.92
Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol (2002) 2.79
Motor imagery: a backdoor to the motor system after stroke? Stroke (2006) 2.60
Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage (2003) 2.52
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke (2008) 2.39
Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke (2003) 2.25
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol (2002) 2.25
Imaging of acute stroke. Lancet Neurol (2006) 2.25
Motor imagery after stroke: relating outcome to motor network connectivity. Ann Neurol (2009) 2.17
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci (2008) 2.15
Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke (2012) 2.13
The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust (2002) 2.13
Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location. J Neurol Sci (2013) 2.11
How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke (2008) 2.09
Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology (2012) 2.06
National healthline responses to a stroke scenario: implications for early intervention. Stroke (2007) 2.06
Emergency department workload increase: dependence on primary care? J Emerg Med (2009) 2.04
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03
Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med (2010) 1.97
World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94
Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis (2010) 1.93
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke (2004) 1.81
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Post-stroke plastic reorganisation in the adult brain. Lancet Neurol (2003) 1.72
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain (2003) 1.72
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust (2007) 1.71
Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology (2013) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke (2005) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging (2007) 1.64
The physiological significance of the time-to-maximum (Tmax) parameter in perfusion MRI. Stroke (2010) 1.62
Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust (2003) 1.61
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci (2009) 1.61
Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke (2003) 1.59
Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med (2004) 1.56
The relationship between motor deficit and hemisphere activation balance after stroke: A 3T fMRI study. Neuroimage (2006) 1.55
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke (2011) 1.52
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis (2013) 1.52
Behavioral and neurofunctional changes over time in healthy and aphasic subjects: a PET Language Activation Study. Stroke (2003) 1.51
Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain (2009) 1.50
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase (2005) 1.49
Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke. J Clin Neurosci (2010) 1.49
Semantic and episodic memory of music are subserved by distinct neural networks. Neuroimage (2003) 1.49
Association between early returns and frequent ED visits at a rural academic medical center. Am J Emerg Med (2003) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47
Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke (2006) 1.45
Is neural activation within the rescued penumbra impeded by selective neuronal loss? Brain (2013) 1.45
Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44
MRI and stroke: why has it taken so long? Lancet (2007) 1.44
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain (2010) 1.44
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
Mismatch-based delayed thrombolysis: a meta-analysis. Stroke (2009) 1.41
Acute stroke imaging research roadmap. AJNR Am J Neuroradiol (2008) 1.41
When to measure lipid profile after stroke? Cerebrovasc Dis (2005) 1.39
Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab (2013) 1.36
The Virtual International Stroke Trials Archive. Stroke (2007) 1.34
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage (2003) 1.33
Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage: a multicentre MRI cohort study. J Neurol Neurosurg Psychiatry (2013) 1.32
Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology (2013) 1.29
Violence in the emergency department: a national survey of emergency medicine residents and attending physicians. J Emerg Med (2010) 1.27
Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp (2004) 1.26
Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke (2009) 1.23
Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain (2010) 1.22
How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol (2011) 1.22
Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke (2012) 1.21
Motor imagery after subcortical stroke: a functional magnetic resonance imaging study. Stroke (2009) 1.21
Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke (2012) 1.21
The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain (2002) 1.20
Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke (2004) 1.20
Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology (2013) 1.20
The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke (2010) 1.20
White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology (2013) 1.18
The neural correlates of inner speech defined by voxel-based lesion-symptom mapping. Brain (2011) 1.18
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Re-experiencing old memories via hippocampus: a PET study of autobiographical memory. Neuroimage (2004) 1.17
Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke (2006) 1.17
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16
Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain (2011) 1.16